Limited Time Offer
Get $1000 towards your
first investment
Start investing in private markets with Linqto – your access to disruptive startups and pre-IPO companies.
*Terms and conditions apply. See details
RxSight, formerly known as Calhoun Vision, is an ophthalmic medical technology company based in Aliso Viejo, California. The company specializes in developing and manufacturing adjustable intraocular lenses, which can be customized after cataract surgery to optimize vision results. This innovative approach has positioned RxSight as a notable player in the healthcare sector, particularly in the field of eye care.
Since its inception, RxSight has successfully raised a total of $215.91 million in funding, demonstrating investor confidence in its technology and market potential. The company's focus on addressing the needs of eye care professionals and patients requiring cataract surgery has helped it carve out a niche in the competitive medical device industry.
While there is currently no concrete information available regarding RxSight's IPO prospects, the company's innovative product offerings and successful fundraising history may position it as an interesting potential investment opportunity in the future. However, it's important to note that any discussions about a possible RxSight IPO remain speculative at this time.
Factors that could influence RxSight's decision to go public in the future might include market conditions in the healthcare sector, the company's financial performance, and its growth strategy. As with any potential investment, it's crucial for interested parties to conduct thorough research and stay informed about any official announcements from the company regarding its plans for going public.
Get $1000 towards your
first investment
*Terms and conditions apply. See details
While RxSight's IPO prospects remain uncertain, investors eager to explore opportunities in the innovative medical technology space don't have to wait. At Linqto, we offer members access to interests in promising private companies before they go public. Our platform provides the opportunity to invest in potential leaders in the healthcare and medical device sectors, with lower minimum investments than traditional private equity opportunities. This could allow you to diversify your portfolio and potentially benefit from the growth of emerging industry leaders like RxSight before they hit the public markets.
*These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO. The information provided above is based on current online discussions and is not intended as investment advice. Linqto does not endorse or guarantee the accuracy of this information, and we strongly recommend conducting your own research or consulting with a professional advisor before making any investment decisions. Linqto cannot be held liable for any investment outcomes resulting from the use of this information.
